e-learning
resources
Munich 2014
Monday, 08.09.2014
Latest insights in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Surfactant protein D is dysregulated in severe asthma
R. M. Mackay, C. Grainge, L. Lau, C. Barber, H. Clark, P. Howarth (southampton, United Kingdom; Newcastle, Australia)
Source:
International Congress 2014 – Latest insights in airway diseases
Session:
Latest insights in airway diseases
Session type:
Thematic Poster Session
Number:
2824
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. M. Mackay, C. Grainge, L. Lau, C. Barber, H. Clark, P. Howarth (southampton, United Kingdom; Newcastle, Australia). LATE-BREAKING ABSTRACT: Surfactant protein D is dysregulated in severe asthma. Eur Respir J 2014; 44: Suppl. 58, 2824
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Blood cytotoxic/pro-inflammatory mediators in severe asthma
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
LATE-BREAKING ABSTRACT: Critical role of proton-sensing OGR1 in dendritic cells in development of asthma
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014
LATE-BREAKING ABSTRACT: The effect of temperature during sputum processing on inflammatory markers
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Vitamin D levels and bronchial obstruction in childhood
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Investigating airway HMGB1 redox state in health and asthma
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014
Vitamin D status and lung function in children with asthma
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Proteins regulating iron metabolism in asthmatic children
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Fungal sensitization in patients with moderate and severe asthma
Source: International Congress 2014 – Clinical allergy
Year: 2014
Altered airway microbiome in stable asthma
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014
LATE-BREAKING ABSTRACT: Phosphoinositide-dependent protein kinase-1 mediates inhibitory effects on eosinophils.
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014
LATE-BREAKING ABSTRACT: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014
Investigating the role of BAFF in murine models of allergic asthma
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Autoreactivity in patients with combined COPD and asthma phenotype
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014
Allergic and non-allergic childhood asthma is characterized by novel biomarkers and signaling pathways
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
LATE-BREAKING ABSTRACT: BAFF: a self-perpetuating mechanism of B cell activation in COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Serum vitamin D levels In patients with asthma
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
LATE-BREAKING ABSTRACT: Using eosinophilic phenotype to characterize asthma control.
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Genetic polymorphisms in early and late-onset bronchial asthma
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept